Ultrasound-guided ChondroFiller injection for hip cartilage defectsChondroFiller is an acellular collagen scaffold that recruits the patient's own cells to repair focal hip cartilage defects. Treatment works best for Grade III–IV lesions greater than 2 cm² in Tönnis Grade 0–1 joints.ChondroFiller is an acellular collagen scaffold that recruits the patient's own cells to repair focal hip cartilage defects. Treatment works best for Grade III–IV lesions greater than 2 cm² in Tönnis Grade 0–1 joints.
OATS mosaicplasty for sports knee cartilage repairIn a ten-year trial of athletes, osteochondral autograft transfer showed 14% treatment failure versus 38% for microfracture, a divergence emerging between years five and ten because fibrocartilage stimulated by microfracture degrades under repetitive athletic loading whilst transplanted hyaline cartilage retains structural integrity.In a ten-year trial of athletes, osteochondral autograft transfer showed 14% treatment failure versus 38% for microfracture, a divergence emerging between years five and ten because fibrocartilage stimulated by microfracture degrades under repetitive athletic loading whilst transplanted hyaline cartilage retains structural integrity.
ChondroFiller injection cost in the UKChondroFiller costs £3,000–£8,000 in the UK, with price determined entirely by defect size; the number of implant boxes required is confirmed only after imaging review.ChondroFiller costs £3,000–£8,000 in the UK, with price determined entirely by defect size; the number of implant boxes required is confirmed only after imaging review.
What IKDC and MOCART data show about ChondroFillerChondroFiller injection improves knee function by an average of 30 points on the IKDC scale — double the clinically meaningful threshold — across independent studies, though evidence derives from small cohorts of younger patients with focal cartilage defects.ChondroFiller injection improves knee function by an average of 30 points on the IKDC scale — double the clinically meaningful threshold — across independent studies, though evidence derives from small cohorts of younger patients with focal cartilage defects.
Questions to ask before a ChondroFiller injectionChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.ChondroFiller is a Type I collagen hydrogel injected into the joint where it recruits the patient's own progenitor cells to repair cartilage over months rather than days. Specific suitability criteria apply; questions a patient asks beforehand substantially influence whether expectations align with realistic outcomes.
Knee cartilage damage symptoms and who to seeArticular cartilage lacks a blood supply and cannot repair itself; untreated defects larger than 1 cm risk progressive worsening and osteoarthritis.Articular cartilage lacks a blood supply and cannot repair itself; untreated defects larger than 1 cm risk progressive worsening and osteoarthritis.
ChondroFiller repeat injections and long-term repairChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.ChondroFiller recruits the patient's progenitor cells into a collagen scaffold that degrades over 12–18 months whilst repair tissue develops; 81% of hip patients achieved good or excellent outcomes at three to five years, but success depends heavily on whether osteoarthritis is early-stage or advanced.
ChondroFiller injection for talar dome cartilage defectsChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.ChondroFiller is an ultrasound-guided collagen scaffold injection that recruits the patient's own progenitor cells to repair talar cartilage defects over 12–24 months, positioned for lesions exceeding 15 mm that fail conservative care.
Knee Cartilage Repair and PreservationArticular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.Articular cartilage lacks blood vessels, so when damaged it forms fibrocartilage—a mechanically inferior scar tissue that typically deteriorates within two to three years. This biological constraint shapes every treatment option, from temporary symptom relief to procedures attempting true cartilage regeneration.
Choosing a UK ChondroFiller providerChondroFiller is a collagen scaffold injected under ultrasound guidance that recruits the patient's own repair cells into focal cartilage defects. It does not work for diffuse osteoarthritis, which requires surgical escalation instead.ChondroFiller is a collagen scaffold injected under ultrasound guidance that recruits the patient's own repair cells into focal cartilage defects. It does not work for diffuse osteoarthritis, which requires surgical escalation instead.
When cartilage repair is the right choiceCartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.Cartilage repair is suited to younger, active patients with isolated damage in otherwise healthy joints where conservative care has not worked. It is mechanistically impossible when underlying bone is worn smooth, degeneration spans multiple compartments, or malalignment and instability persist uncorrected.
ChondroFiller injection side effects and safetySwelling and stiffness peak at 24 hours following ChondroFiller injection and resolve within 72 hours as normal tissue responses; the procedure has recorded zero serious adverse effects across more than 19,000 cases since 2013.Swelling and stiffness peak at 24 hours following ChondroFiller injection and resolve within 72 hours as normal tissue responses; the procedure has recorded zero serious adverse effects across more than 19,000 cases since 2013.